Eiken Chemical Co. Ltd. | Ownership
Companies that own Eiken Chemical Co. Ltd.
Matthews International Capital Management LLC
3,820,000
8.77%
561,200
0.25%
01/29/2018
FIL Investments (Japan) Ltd.
3,062,100
7.03%
-599,100
0.51%
03/30/2018
Asset Management One Co., Ltd.
2,809,000
6.45%
0
0.04%
03/31/2018
T. Rowe Price International Ltd.
2,024,600
4.65%
-802,800
0.08%
01/15/2018
Sumitomo Mitsui Asset Management Co., Ltd.
1,955,000
4.49%
-439,200
0.24%
01/31/2018
Norges Bank Investment Management
869,198
2%
139,398
0%
12/31/2017
The Vanguard Group, Inc.
732,900
1.68%
4,000
0%
07/31/2018
T. Rowe Price International Ltd. (Japan)
572,000
1.31%
102,500
0.76%
06/30/2018
Nomura Asset Management Co., Ltd.
551,098
1.27%
-388,300
0.01%
07/31/2018
Goldman Sachs Asset Management Co. Ltd. (Japan)
480,699
1.1%
36,999
0.56%
06/30/2018
Address |
Yamaguchi Building, 7/F Tokyo Tokyo 110 Japan
|
Employees
|
- |
Website |
http://www.eiken.co.jp |
Updated |
07/08/2019 |
Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics products and equipment. It operates through Clinical Diagnostics and Testing of Food and Environment business divisions. The Clinical Diagnostics division handles the manufacture of clinical diagnostic products and services. |